Insights from ASH 2025, including anticipated presentations, key takeaways, and how emerging research in paroxysmal nocturnal ...

An oral pyruvate kinase (PK) activator, mitapivat becomes the only approved option for treating anemia in both ...

Approval was based on the phase 3 ENERGIZE and ENERGIZE-T studies evaluating the safety and efficacy of mitapivat in adults with alpha- or beta-thalassemia.

Dr. Dwivedi's work stands out for its integration of advanced homoeopathic principles with sound clinical judgment, ethical practice, and long-term outcome assessment. He consistently underscores that ...

Agios Pharmaceuticals has announced a major regulatory milestone with the U.S. Food and Drug Administration approving ...

The North Texas Region of the Red Cross operates two fixed donation sites in the area: the Irving Blood and Platelet Donation ...

After raising $293 million in the IPO, Insilico Medicine aims to become “a massive source of innovative drugs for pharma ...

Feeling cold all the time isn’t just weather-related. Research links it to anemia, thyroid issues, slow metabolism, and ...

Agios Pharmaceuticals shares surged after the FDA approved expanded use of its drug mitapivat for treating anemia in alpha- and beta-thalassemia patients.

A recent study revealed that iron deficiency without anemia is common among adults with moderate-to-severe atopic dermatitis ...

Dr. Nassir Marrouche is director of the Heart and Vascular Institute at Tulane University with a subspecialty in ...

Can vitamin B12 deficiency be a sign of cancer? Learn the symptoms, risks, connection to cancer, treatments, and why this ...